State Street Corp Biodesix Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Biodesix Inc stock. As of the latest transaction made, State Street Corp holds 288,550 shares of BDSX stock, worth $398,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares

288,550

Previous 288,550 -0.0%

Holding current value

$398,198

Previous $441,000 16.33%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.21 - $1.71 $15,972 - $22,572	13,200 Added 4.79%	288,550 $441,000
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.88 $281,456 - $472,444	251,300 Added 1044.91%	275,350 $338,000
Q4 2022 Feb 14, 2023	BUY	$0.98 - $2.3 $10,878 - $25,529	11,100 Added 85.71%	24,050 $55,000
Q3 2022 Nov 15, 2022	SELL	$1.24 - $2.89 $6,200 - $14,450	-5,000 Reduced 27.86%	12,950 $16,000
Q2 2022 Aug 15, 2022	SELL	$1.32 - $2.12 $160,629 - $257,980	-121,689 Reduced 87.15%	17,950 $29,000
Q1 2022 May 16, 2022	BUY	$1.69 - $5.81 $4,542 - $15,617	2,688 Added 1.96%	139,639 $236,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $8.67 $2,842 - $6,025	695 Added 0.51%	136,951 $724,000
Q3 2021 Nov 15, 2021	BUY	$6.6 - $12.78 $241,771 - $468,156	36,632 Added 36.77%	136,256 $1.12 Million
Q2 2021 Aug 16, 2021	BUY	$12.14 - $20.35 $738,634 - $1.24 Million	60,843 Added 156.89%	99,624 $1.32 Million
Q1 2021 May 17, 2021	BUY	$16.87 - $31.21 $75,020 - $138,790	4,447 Added 12.95%	38,781 $788,000
Q4 2020 Feb 16, 2021	BUY	$10.89 - $20.16 $373,897 - $692,173	34,334 New	34,334 $692,000

Others Institutions Holding BDSX

# of Institutions

Shares Held

62.3M

Call Options Held

2.6K

Put Options Held

10.1K

View Full List

About BIODESIX INC

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $55.2M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

More about BDSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Biodesix Inc Transaction History